Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2770 - Analysis of the impact of the tumours committee on the multidisciplinary approach to head and neck epidermoid cancer in our institution


10 Sep 2017


Poster display session


Cancers in Adolescents and Young Adults (AYA);  Head and Neck Cancers


María José Martínez-Ortiz


Annals of Oncology (2017) 28 (suppl_5): v372-v394. 10.1093/annonc/mdx374


M.J. Martínez-Ortiz1, P. Cerezuela1, G. Marin Zafra2, J. Balsalobre1, J. Díaz-Manzano3, J. Trujillo4

Author affiliations

  • 1 Medical Oncology, Hospital Universitario Santa Lucia, 30202 - Cartagena/ES
  • 2 Hematology And Medical Oncology, Hospital Universitario Morales Meseguer, 30008 - Murcia/ES
  • 3 Orl, HCU Virgen de la Arrixaca, 30120 - El Palmar/ES
  • 4 Internal Medicine, Hospital Universitario Santa Lucia, 30202 - Cartagena/ES


Abstract 2770


The objectives are to define the characteristics of people with HNSCC treated in our area and quantify the impact of the committee on the staging, the change in the initial treatment proposed to determine whether the selection of treatment by the multidisciplinary team (MDT) influences therapeutic compliance.


Observational retrospective study of two cohorts, which aims to analyse the variables in the cohort of patients handled by an MDT with respect to the patients without an MDT. We included all patients with an initial diagnosis of HNSCC at our centre between 2005 and 2012. The MDT cohort comprised those from 01/01/2009 to 31/12/2012. With access to the Pathological Anatomy database, the records of the MDT, the archived and computerised medical history, we collected the endpoints related to the patient (age, sex, ECOG), the tumour (date of diagnosis, location, and TNM stage), the treatment (therapy selected, change in treatment, compliance, reason for default). Definitive sample consists of 408 patients. A descriptive analysis is given of the clinical characteristics of the sample, together with the comparative bivariate analysis of these characteristics in the cohorts.


Our population presents age (mean) 64.2y (SD 12.4), male 82.6%, ECOG


The population served in our area presents clinical characteristics similar to those of other series published in our and other countries. The MDT improved the staging of the tumour before treatment in a statistically significant way. The change in treatment is higher, so as to be statistically significant, when the therapeutic planning is addressed by an MDT. No statistically significant difference was observed in therapeutic compliance rates when treatment was decided by the MDT.

Clinical trial identification

Legal entity responsible for the study

María José Martínez-Ortiz




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.